Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Javid, R. Kazemi, M. Dehghani, Hossein Samani (2021)
Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxisUrology Case Reports, 36
Christine Kempton, Thomas Abshire, R. Deveras, W. Hoots, Joan Gill, C. Kessler, Nigel Key, Barbara Konkle, Philip Kuriakose, Donald Macfarlane, Garrett Bergman (2012)
Pharmacokinetics and safety of OBI‐1, a recombinant B domain‐deleted porcine factor VIII, in subjects with haemophilia AHaemophilia, 18
E. Zanon, S. Pasca, A. Borchiellini, C. Lodigiani, A. Molinari, C. Ambaglio, F. Valeri, P. Preti, P. Moscatelli, P. Simioni (2020)
Susoctocog-alfa (Obizur®) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experience.Blood transfusion = Trasfusione del sangue
C. Eastin, T. Eastin (2020)
Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe Journal of Emergency Medicine, 58
J. Thachil, N. Tang, S. Gando, A. Falanga, M. Cattaneo, M. Levi, Cary Clark, T. Iba (2020)
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19Journal of Thrombosis and Haemostasis, 18
A. Coppola, A. Tagliaferri, G. Rivolta, Gabriele Quintavalle, M. Franchini (2020)
Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding DisordersSeminars in Thrombosis and Hemostasis, 46
W. Guan, Z. Ni, Yu Hu, W. Liang, C. Ou, Jianxing He, Lei Liu, H. Shan, C. Lei, D. Hui, Bin Du, Lanjuan Li, G. Zeng, K. Yuen, Ru-chong Chen, C. Tang, Taojiao Wang, Ping-yan Chen, J. Xiang, Shi‐yue Li, Jin-lin Wang, Ziyao Liang, Yi-xiang Peng, Li Wei, Yong Liu, Ya-hua Hu, P. Peng, Jian-ming Wang, Ji-yang Liu, Zhong Chen, Gang Li, Zhi-jian Zheng, Shao-qin Qiu, Jie Luo, C. Ye, Shao-yong Zhu, N. Zhong (2020)
Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe New England Journal of Medicine
M. Reding (2006)
Immunological aspects of inhibitor developmentHaemophilia, 12
S. Nishida, T. Kawasaki, H. Kashiwagi, A. Morishima, Y. Hishitani, M. Kawai, T. Hirano, T. Ishii, K. Hagihara, Y. Shima, M. Narazaki, A. Ogata, Y. Oka, T. Kishimoto, Toshio Tanaka (2011)
Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumabModern Rheumatology, 21
L. Carsana, A. Sonzogni, A. Nasr, R. Rossi, A. Pellegrinelli, P. Zerbi, R. Rech, R. Colombo, S. Antinori, M. Corbellino, M. Galli, E. Catena, A. Tosoni, A. Gianatti, M. Nebuloni (2020)
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive studyThe Lancet. Infectious Diseases, 20
F. Baudo, P. Collins, A. Huth‐Kühne, H. Lévesque, P. Marco, L. Nemes, F. Pellegrini, L. Tengborn, P. Knoebl (2012)
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry.Blood, 120 1
P. Turecek, S. Romeder-Finger, C. Apostol, A. Bauer, A. Crocker-Buqué, D. Burger, R. Schall, H. Gritsch (2016)
A world‐wide survey and field study in clinical haemostasis laboratories to evaluate FVIII:C activity assay variability of ADYNOVATE and OBIZUR in comparison with ADVATEHaemophilia, 22
K. Martin, R. Kasthuri, M. Mooberry, S-L Chen, N. Key, A. Ma (2016)
Lower doses of recombinant porcine factor VIII maintain excellent haemostatic efficacyHaemophilia, 22
A. Allison, E. Eugui (2000)
Mycophenolate mofetil and its mechanisms of action.Immunopharmacology, 47 2-3
N. Tang, Huan Bai, Xing Chen, Jiale Gong, Dengju Li, Ziyong Sun (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathyJournal of Thrombosis and Haemostasis, 18
J. Thachil, A. Srivastava (2020)
SARS-2 Coronavirus–Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?Seminars in Thrombosis and Hemostasis, 46
A. Tiede, P. Collins, P. Knoebl, J. Teitel, C. Kessler, M. Shima, G. Minno, R. d’Oiron, P. Salaj, V. Jiménez‐Yuste, A. Huth‐Kühne, P. Giangrande (2020)
International recommendations on the diagnosis and treatment of acquired hemophilia AHaematologica, 105
P. Collins, F. Baudo, P. Knoebl, H. Lévesque, L. Nemes, F. Pellegrini, P. Marco, L. Tengborn, A. Huth‐Kühne (2012)
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).Blood, 120 1
I. Patel, A. Akoluk, S. Douedi, Vandan Upadhyaya, U. Mazahir, E. Costanzo, D. Flynn (2020)
Life-Threatening Psoas Hematoma due to Retroperitoneal Hemorrhage in a COVID-19 Patient on Enoxaparin Treated With Arterial Embolization: A Case ReportJournal of Clinical Medicine Research, 12
J. Grein, N. Ohmagari, Daniel Shin, G. Diaz, E. Asperges, A. Castagna, T. Feldt, Gary Green, M. Green, F. Lescure, E. Nicastri, Rentaro Oda, Kikuo Yo, E. Quiros-Roldan, A. Studemeister, John Redinski, Seema Ahmed, J. Bernett, D. Chelliah, Danny Chen, S. Chihara, Stuart Cohen, J. Cunningham, A. Monforte, S. Ismail, H. Kato, G. Lapadula, E. L’her, T. Maeno, Sumit Majumder, M. Massari, M. Mora-Rillo, Y. Mutoh, Duc Nguyen, E. Verweij, A. Zoufaly, A. Osinusi, A. DeZure, Yang Zhao, Lijie Zhong, A. Chokkalingam, E. Elboudwarej, L. Telep, Leighann Timbs, Ilana Henne, Scott Sellers, H. Cao, Susanna Tan, Lucinda Winterbourne, P. Desai, R. Mera, A. Gaggar, R. Myers, D. Brainard, R. Childs, T. Flanigan (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19The New England Journal of Medicine
P. Knoebl, P. Marco, F. Baudo, P. Collins, A. Huth‐Kühne, L. Nemes, Fabio Pellegrini, L. Tengborn, H. Lévesque, G. Aspoek, M. Heistinger, P. Knöbl, A. Mäkipernaa, H. André, A. Aouba, S. Bellucci, P. Beurrier, Hannes Borg, L. Darnige, J. Devignes, R. d’Oiron, P. Gautier, S. Girault, Y. Gruel, V. Guérin, N. Hézard, M. Khellaf, M. Koenig, F. Lifermann, R. Marlu, J. Ninet, J. Peynet, T. Quéméneur, C. Rothschild, N. Schleinitz, M. Sigaud, S. Trouillier, S. Voisin, A. Giebl, K. Holstein, R. Loreth, U. Steigerwald, A. Tiede, G. Theodossiades, G. Radványi, Á. Schlammadinger, G. Barillari, S. Pasca, T. Caimi, L. Contino, G. Minno, A. Cerbone, M. Minno, M. D'inca, A. Falanga, A. Maggioni, T. Lerede, M. Franchini, G. Gaidano, L. Paoli, G. Gamba, R. Ghirardi, M. Girotto, D. Tasca, E. Grandone, G. Tiscia, D. Imberti, Alfonso Iorio, R. Landolfi, L. Gennaro, L. Novarese, G. Mariani, M. Lapecorella, M. Marietta, P. Pedrazzi, M. Mazzucconi, C. Santoro, M. Morfini, S. Linari, S. Moratelli, R. Paolini, G. Piseddu, R. Poggio, E. Pogliani, M. Carpenedo, C. Remiddi, E. Santagostino, M. Mancuso, R. Santoro, G. Papaleo, P. Schinco, A. Borchiellini, F. Valeri, A. Scortechini, S. Siragusa, G. Sottilotta, A. Squizzato, R. Sartori, G. Tagariello, A. Tagliaferri, C. Perna, G. Rivolta, S. Testa, O. Paoletti, V. Toschi, E. Zanon, B. Brandolini, K. Hamulyák, P. Kamphuisen, B. Gorkom, F. Leebeek, N. Marten, I. Novakova, R. Schutgens, P. Linden, J. Esser, J. Meer, P. Ypma, M. Campos, Carolina Aguilar, C. Altisent, N. Bermejo, R. Campo, M. Arguelles, R. Boullosa, M. Pimentel, V. Jiménez‐Yuste, L. Jose-Felix, M. Pascual, M. Mingot, R. Garrido, Nz Gonzale, M. Garcia, A. Rodríguez-Huerta, C. Sedano, A. Munoz, F. Baghaei, F. Boehlen, W. Korte, P. Chowdary, G. Evans, S. Pavord, S. Rangarajan, J. Wilde, Each Contributors (2012)
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)Journal of Thrombosis and Haemostasis, 10
C. Kessler, A. Ma, H. Al-Mondhiry, R. Gut, D. Cooper (2016)
Assessment of acquired hemophilia patient demographics in the United States: the Hemostasis and Thrombosis Research Society RegistryBlood Coagulation & Fibrinolysis, 27
F. Klok, M. Kruip, N. Meer, M. Arbous, D. Gommers, K. Kant, F. Kaptein, J. Paassen, M. Stals, M. Huisman, H. Endeman (2020)
Incidence of thrombotic complications in critically ill ICU patients with COVID-19Thrombosis Research, 191
M. Mihara, Y. Ohsugi, T. Kishimoto (2009)
Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti‐interluekin‐6 receptor antibodyBioFactors, 35
Dawei Wang, Bo Hu, Chang Hu, Fangfang Zhu, Xing Liu, Jing Zhang, Binbin Wang, Hui Xiang, Zhenshun Cheng, Y. Xiong, Yan Zhao, Yirong Li, Xinghuan Wang, Z. Peng (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.JAMA
J. Beigel, K. Tomashek, L. Dodd, A. Mehta, B. Zingman, A. Kalil, E. Hohmann, H. Chu, A. Luetkemeyer, S. Kline, D. Castilla, R. Finberg, K. Dierberg, V. Tapson, L. Hsieh, T. Patterson, R. Paredes, D. Sweeney, W. Short, G. Touloumi, D. Lye, N. Ohmagari, M. Oh, G. Ruiz-Palacios, T. Benfield, G. Fätkenheuer, M. Kortepeter, R. Atmar, C. Creech, J. Lundgren, A. Babiker, S. Pett, J. Neaton, T. Burgess, Tyler Bonnett, Michelle Green, M. Makowski, A. Osinusi, S. Nayak, H. Lane (2020)
Remdesivir for the Treatment of Covid-19 — Final ReportThe New England Journal of Medicine
R. Kruse-Jarres, J. St-Louis, A. Greist, A. Shapiro, Hedy Smith, P. Chowdary, A. Drebes, E. Gomperts, C. Bourgeois, Min Mo, A. Novack, H. Farin, B. Ewenstein (2015)
Efficacy and safety of OBI‐1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia AHaemophilia, 21
M. Franchini, S. Vaglio, G. Marano, C. Mengoli, S. Gentili, S. Pupella, G. Liumbruno (2017)
Acquired hemophilia A: a review of recent data and new therapeutic optionsHematology, 22
J. Mahlangu, T. Andreeva, D. Macfarlane, Christopher Walsh, N. Key (2017)
Recombinant B‐domain‐deleted porcine sequence factor VIII (r‐pFVIII) for the treatment of bleeding in patients with congenital haemophilia A and inhibitorsHaemophilia, 23
M. Stemberger, P. Möhnle, J. Tschöp, L. Ney, M. Spannagl, M. Reincke (2016)
Successful bleeding control with recombinant porcine factor VIII in reduced loading doses in two patients with acquired haemophilia A and failure of bypassing agent therapyHaemophilia, 22
F. Zhou, Ting Yu, R. Du, Guohui Fan, Y. Liu, Zhibo Liu, J. Xiang, Ye-ming Wang, Bin Song, Xiaoying Gu, Lulu Guan, Yuan Wei, Hui Li, Xudong Wu, Jiuyang Xu, Shengjin Tu, Yi Zhang, Hua Chen, B. Cao (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyLancet (London, England), 395
K. Hodges, M. Mubashir, Joshua Insler, J. Estep, E. Hsich, M. Tong, S. Insler, E. Soltesz (2020)
Successful management of COVID‐19 and associated coagulopathy in a patient with durable left ventricular assist deviceJournal of Cardiac Surgery, 35
M. Tarantino, A. Cuker, B. Hardesty, J. Roberts, M. Sholzberg (2017)
Recombinant porcine sequence factor VIII (rpFVIII) for acquired haemophilia A: practical clinical experience of its use in seven patientsHaemophilia, 23
N. Tang, Dengju Li, Xiong Wang, Ziyong Sun (2020)
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 18
Immunosuppressive treatment and bypassing agents are used to treat acquired haemophilia A (AHA). On the other hand, COVID-19 infection induces a hypercoagulable state. Managing bleeding, risk of thrombosis, bypassing agents, active infection and immunosuppressive treatment can be challenging. A 72-year-old man was diagnosed with acquired hemophilia A. He received steroids, rituximab and recombinant activated factor VII (rFVIIa). He developed severe SARS-CoV-2 infection. Due to thrombotic risk, he received low-molecular-weight heparin (LMWH) and developed an iliopsoas hematoma. Because of the risk of thrombosis, treatment with recombinant porcine FVIII (rpFVIII) was requested. Tocilizumab was administered for treatment of SARS-CoV-2 infection and unexpected improvement of FVIII levels was noted. Concluding, rpFVIII treatment was well tolerated and effective, easy to monitor and to administer. Tocilizumab may play a role as immunosuppressive treatment for AHA. The role of LMWH remains to be established in patients with coagulopathies.
Blood Coagulation & Fibrinolysis – Wolters Kluwer Health
Published: Sep 5, 2022
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.